EBS aims to take cataract treatment from the operating theatre to the high street as company signs licensing deal in China – Licensing and equity investment deal with China’s Haoguang Bio-tech, a wholly owned subsidiary of Boye Biotech – EBS has raised around £3m to date and is about to embark on a £5m series […]
